Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Non Operating Investment Income (2026)

Icon's (ICLR) quarterly Non Operating Investment Income came in at -$32.9 million in Q2 2026.

Analysis

Icon (ICLR) Non Operating Investment Income (2026) Analysis & Trends

Icon (ICLR) has reported Non Operating Investment Income for 1 consecutive years, with -$32.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to -$32.9 million in Q2 2026; TTM through Jun 2026 was -$32.9 million, a N/A change from a year earlier, with the FY2023 full-year figure at -$6.2 million, changed N/A from the prior year.
  • Non Operating Investment Income was -$32.9 million for Q2 2026 at Icon.
  • Over five years, Non Operating Investment Income peaked at -$32.9 million in Q2 2026 and troughed at -$32.9 million in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -32.95 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 1.99 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -32.95 Mn